Literature DB >> 18614931

Candida albicans-induced DC activation partially restricts HIV amplification in DCs and increases DC to T-cell spread of HIV.

Laurence Vachot1, Vennansha G Williams, Julian W Bess, Jeffrey D Lifson, Melissa Robbiani.   

Abstract

Dendritic cells (DCs) are central to the innate and adaptive responses needed to control pathogens, yet HIV exploits DCs to promote infection. The influence of other pathogens on DC-HIV interplay has not been extensively studied. We used Candida albicans (Candida) as a model pathogen which elicits innate DC responses that are likely important in controlling Candida by healthy immune systems. HIV did not impede Candida-specific DC activation. Candida-induced CD80 and CD83 upregulation was greater in DCs that had captured HIV, coinciding with increased amplification in presence of T cells and reduced but persistent low-level DC infection. In contrast, HIV-infected DCs matured normally in response to Candida, but this did not shut down HIV replication in DCs, and again Candida augmented HIV amplification in DC-T-cell mixtures. HIV-infected DCs secreted more IL-10 and IL-1beta earlier than uninfected DCs and initially induced a higher frequency of CD4CD25FoxP3 T-regulatory cells in response to Candida. Elevated early IL-10 production in cocultures was evident only when azidothymidine (AZT) was included to limit T-regulatory cell infection and destruction. Therefore, HIV manipulates the DC's innate and adaptive responses to Candida to further augment HIV spread, ultimately destroying the cells needed to limit candidiasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614931     DOI: 10.1097/QAI.0b013e3181776bc7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

1.  Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.

Authors:  Morgan A Reuter; Nicole D Pecora; Clifford V Harding; David H Canaday; David McDonald
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.

Authors:  Edith Jasny; Suzanne Geer; Ines Frank; Panagiotis Vagenas; Meropi Aravantinou; Andres M Salazar; Jeffrey D Lifson; Michael Piatak; Agegnehu Gettie; James L Blanchard; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

3.  Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.

Authors:  Ines Frank; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.

Authors:  Susanna Trapp; Nina R Derby; Rachel Singer; Andrew Shaw; Vennansha G Williams; Stuart G Turville; Julian W Bess; Jeffrey D Lifson; Melissa Robbiani
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

5.  Penicillium marneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells.

Authors:  Yan Qin; Yuye Li; Wan Liu; Renrong Tian; Qianqian Guo; Shaoyou Li; Hongbin Li; Daojun Zhang; Yongtang Zheng; Li Wu; Ke Lan; Jianhua Wang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Candida albicans delays HIV-1 replication in macrophages.

Authors:  Christian Rodriguez Rodrigues; Federico Remes Lenicov; Carolina Jancic; Juan Sabatté; Mercedes Cabrini; Ana Ceballos; Antonela Merlotti; Heidi Gonzalez; Matías Ostrowski; Jorge Geffner
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

7.  Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity.

Authors:  Stuart G Turville; Meropi Aravantinou; Todd Miller; Jessica Kenney; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Tom M Zydowsky; Michael Piatak; Julian W Bess; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

Review 8.  HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Authors:  Charles R Rinaldo
Journal:  Scientifica (Cairo)       Date:  2013-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.